ID   CX6A2_HUMAN             Reviewed;          97 AA.
AC   Q02221; O00761; Q6GTW6;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   07-APR-2021, entry version 164.
DE   RecName: Full=Cytochrome c oxidase subunit 6A2, mitochondrial;
DE   AltName: Full=Cytochrome c oxidase polypeptide VIa-heart;
DE            Short=COXVIAH;
DE   AltName: Full=Cytochrome c oxidase subunit VIA-muscle;
DE            Short=COX VIa-M;
DE   Flags: Precursor;
GN   Name=COX6A2; Synonyms=COX6A, COX6AH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=1327966; DOI=10.1016/0378-1119(92)90288-z;
RA   Fabrizi G.M., Sadlock J., Hirano M., Mita S., Koga Y., Rizzuto R.,
RA   Zeviani M., Schon E.A.;
RT   "Differential expression of genes specifying two isoforms of subunit VIa of
RT   human cytochrome c oxidase.";
RL   Gene 119:307-312(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9177785; DOI=10.1006/geno.1997.4687;
RA   Bachman N.J., Riggs P.K., Siddiqui N.Y., Makris G.J., Womack J.E.,
RA   Lomax M.I.;
RT   "Structure of the human gene (COX6A2) for the heart/muscle isoform of
RT   cytochrome c oxidase subunit VIa and its chromosomal location in humans,
RT   mice, and cattle.";
RL   Genomics 42:146-151(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   TISSUE SPECIFICITY, FUNCTION, INVOLVEMENT IN MC4DN18, VARIANTS MC4DN18
RP   ARG-39 AND ARG-43, AND CHARACTERIZATION OF VARIANTS MC4DN18 ARG-39 AND
RP   ARG-43.
RX   PubMed=31155743; DOI=10.1002/ana.25517;
RA   Inoue M., Uchino S., Iida A., Noguchi S., Hayashi S., Takahashi T.,
RA   Fujii K., Komaki H., Takeshita E., Nonaka I., Okada Y., Yoshizawa T.,
RA   Van Lommel L., Schuit F., Goto Y.I., Mimaki M., Nishino I.;
RT   "COX6A2 variants cause a muscle-specific cytochrome c oxidase deficiency.";
RL   Ann. Neurol. 86:193-202(2019).
CC   -!- FUNCTION: Component of the cytochrome c oxidase, the last enzyme in the
CC       mitochondrial electron transport chain which drives oxidative
CC       phosphorylation. The respiratory chain contains 3 multisubunit
CC       complexes succinate dehydrogenase (complex II, CII), ubiquinol-
CC       cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III,
CC       CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to
CC       transfer electrons derived from NADH and succinate to molecular oxygen,
CC       creating an electrochemical gradient over the inner membrane that
CC       drives transmembrane transport and the ATP synthase. Cytochrome c
CC       oxidase is the component of the respiratory chain that catalyzes the
CC       reduction of oxygen to water. Electrons originating from reduced
CC       cytochrome c in the intermembrane space (IMS) are transferred via the
CC       dinuclear copper A center (CU(A)) of subunit 2 and heme A of subunit 1
CC       to the active site in subunit 1, a binuclear center (BNC) formed by
CC       heme A3 and copper B (CU(B)). The BNC reduces molecular oxygen to 2
CC       water molecules unsing 4 electrons from cytochrome c in the IMS and 4
CC       protons from the mitochondrial matrix. Plays a role in the assembly and
CC       stabilization of complex IV (PubMed:31155743).
CC       {ECO:0000250|UniProtKB:P32799, ECO:0000269|PubMed:31155743}.
CC   -!- PATHWAY: Energy metabolism; oxidative phosphorylation.
CC       {ECO:0000250|UniProtKB:P32799}.
CC   -!- SUBUNIT: Component of the cytochrome c oxidase (complex IV, CIV), a
CC       multisubunit enzyme composed of 14 subunits. The complex is composed of
CC       a catalytic core of 3 subunits MT-CO1, MT-CO2 and MT-CO3, encoded in
CC       the mitochondrial DNA, and 11 supernumerary subunits COX4I1 (or
CC       COX4I2), COX5A, COX5B, COX6A1 (or COX6A2), COX6B1 (or COX6B2), COX6C,
CC       COX7A2 (or COX7A1), COX7B, COX7C, COX8A and NDUFA4, which are encoded
CC       in the nuclear genome (By similarity). The complex exists as a monomer
CC       or a dimer and forms supercomplexes (SCs) in the inner mitochondrial
CC       membrane with NADH-ubiquinone oxidoreductase (complex I, CI) and
CC       ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex
CC       III, CIII), resulting in different assemblies (supercomplex
CC       SCI(1)III(2)IV(1) and megacomplex MCI(2)III(2)IV(2)) (By similarity).
CC       {ECO:0000250|UniProtKB:P07471}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000250|UniProtKB:P07471}; Single-pass membrane protein
CC       {ECO:0000250|UniProtKB:P07471}.
CC   -!- TISSUE SPECIFICITY: Expressed specifically in heart and muscle
CC       (PubMed:31155743). Not detected in brain, colon, spleen, kidney, liver,
CC       lung and pancreas (PubMed:31155743). {ECO:0000269|PubMed:1327966,
CC       ECO:0000269|PubMed:31155743}.
CC   -!- DISEASE: Mitochondrial complex IV deficiency, nuclear type 18 (MC4DN18)
CC       [MIM:619062]: An autosomal recessive, muscle-specific, mitochondrial
CC       disorder with onset in infancy. MC4DN18 is characterized by hypotonia,
CC       limb and facial muscle weakness, and high arched palate. Some patients
CC       have respiratory insufficiency at birth and cardiomyopathy. Patient
CC       skeletal muscle shows decreased levels and activity of mitochondrial
CC       respiratory complex IV. {ECO:0000269|PubMed:31155743}. Note=The disease
CC       is caused by variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the cytochrome c oxidase subunit 6A family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M83308; AAA52062.1; -; mRNA.
DR   EMBL; U66875; AAC51328.1; -; Genomic_DNA.
DR   EMBL; BC029818; AAH29818.1; -; mRNA.
DR   CCDS; CCDS10712.1; -.
DR   PIR; JC1304; OGHU6A.
DR   RefSeq; NP_005196.1; NM_005205.3.
DR   SMR; Q02221; -.
DR   BioGRID; 107732; 5.
DR   IntAct; Q02221; 10.
DR   STRING; 9606.ENSP00000287490; -.
DR   DrugBank; DB02659; Cholic Acid.
DR   DrugBank; DB04464; N-Formylmethionine.
DR   TCDB; 3.D.4.11.1; the proton-translocating cytochrome oxidase (cox) superfamily.
DR   PhosphoSitePlus; Q02221; -.
DR   BioMuta; COX6A2; -.
DR   DMDM; 116241323; -.
DR   MassIVE; Q02221; -.
DR   PaxDb; Q02221; -.
DR   PeptideAtlas; Q02221; -.
DR   PRIDE; Q02221; -.
DR   ProteomicsDB; 58061; -.
DR   Antibodypedia; 27872; 104 antibodies.
DR   DNASU; 1339; -.
DR   Ensembl; ENST00000287490; ENSP00000287490; ENSG00000156885.
DR   GeneID; 1339; -.
DR   KEGG; hsa:1339; -.
DR   UCSC; uc002ebx.2; human.
DR   CTD; 1339; -.
DR   DisGeNET; 1339; -.
DR   GeneCards; COX6A2; -.
DR   HGNC; HGNC:2279; COX6A2.
DR   HPA; ENSG00000156885; Group enriched (heart muscle, skeletal muscle, tongue).
DR   MalaCards; COX6A2; -.
DR   MIM; 602009; gene.
DR   MIM; 619062; phenotype.
DR   neXtProt; NX_Q02221; -.
DR   OpenTargets; ENSG00000156885; -.
DR   Orphanet; 254905; Isolated cytochrome C oxidase deficiency.
DR   PharmGKB; PA26796; -.
DR   VEuPathDB; HostDB:ENSG00000156885.5; -.
DR   eggNOG; KOG3469; Eukaryota.
DR   GeneTree; ENSGT00940000162257; -.
DR   HOGENOM; CLU_122515_1_1_1; -.
DR   InParanoid; Q02221; -.
DR   OMA; WLHSGHH; -.
DR   OrthoDB; 1591077at2759; -.
DR   PhylomeDB; Q02221; -.
DR   TreeFam; TF105064; -.
DR   PathwayCommons; Q02221; -.
DR   UniPathway; UPA00705; -.
DR   BioGRID-ORCS; 1339; 6 hits in 983 CRISPR screens.
DR   ChiTaRS; COX6A2; human.
DR   GenomeRNAi; 1339; -.
DR   Pharos; Q02221; Tbio.
DR   PRO; PR:Q02221; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; Q02221; protein.
DR   Bgee; ENSG00000156885; Expressed in apex of heart and 125 other tissues.
DR   Genevisible; Q02221; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005751; C:mitochondrial respiratory chain complex IV; IBA:GO_Central.
DR   GO; GO:0004129; F:cytochrome-c oxidase activity; IEA:InterPro.
DR   GO; GO:0030234; F:enzyme regulator activity; IBA:GO_Central.
DR   GO; GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc.
DR   GO; GO:0006123; P:mitochondrial electron transport, cytochrome c to oxygen; IBA:GO_Central.
DR   CDD; cd00925; Cyt_c_Oxidase_VIa; 1.
DR   Gene3D; 4.10.95.10; -; 1.
DR   InterPro; IPR001349; Cyt_c_oxidase_su6a.
DR   InterPro; IPR018507; Cyt_c_oxidase_su6a_CS.
DR   InterPro; IPR036418; Cyt_c_oxidase_su6a_sf.
DR   PANTHER; PTHR11504; PTHR11504; 1.
DR   Pfam; PF02046; COX6A; 1.
DR   PIRSF; PIRSF000277; COX6A1; 1.
DR   SUPFAM; SSF81411; SSF81411; 1.
DR   PROSITE; PS01329; COX6A; 1.
PE   1: Evidence at protein level;
KW   Disease variant; Membrane; Mitochondrion; Mitochondrion inner membrane;
KW   Oxidoreductase; Primary mitochondrial disease; Reference proteome;
KW   Transit peptide; Transmembrane; Transmembrane helix.
FT   TRANSIT         1..12
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000250"
FT   CHAIN           13..97
FT                   /note="Cytochrome c oxidase subunit 6A2, mitochondrial"
FT                   /id="PRO_0000006116"
FT   TOPO_DOM        13..24
FT                   /note="Mitochondrial matrix"
FT                   /evidence="ECO:0000250|UniProtKB:P07471"
FT   TRANSMEM        25..49
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P07471"
FT   TOPO_DOM        50..97
FT                   /note="Mitochondrial intermembrane"
FT                   /evidence="ECO:0000250|UniProtKB:P07471"
FT   VARIANT         39
FT                   /note="S -> R (in MC4DN18; reduced complex IV assembly;
FT                   decreased COX6A2 protein stability)"
FT                   /evidence="ECO:0000269|PubMed:31155743"
FT                   /id="VAR_084183"
FT   VARIANT         43
FT                   /note="C -> R (in MC4DN18; reduced complex IV assembly;
FT                   decreased COX6A2 protein stability)"
FT                   /evidence="ECO:0000269|PubMed:31155743"
FT                   /id="VAR_084184"
FT   CONFLICT        55
FT                   /note="P -> E (in Ref. 1; AAA52062)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   97 AA;  10815 MW;  843AD80319891F1B CRC64;
     MALPLRPLTR GLASAAKGGH GGAGARTWRL LTFVLALPSV ALCTFNSYLH SGHRPRPEFR
     PYQHLRIRTK PYPWGDGNHT LFHNSHVNPL PTGYEHP
//
